
The Star-Ledger - NJ.com
<img alt="" height="1" width="1" />
Pfizer pulls leukemia drug from US market
Reuters
WASHINGTON (Reuters) - Drugmaker Pfizer Inc is pulling a decade-old leukemia medicine off the US market after a study found a higher death rate and no benefit for patients. Mylotarg won approval under an abbreviated process to help bring treatments for ...
Pfizer to Withdraw a Cancer DrugWall Street Journal
FDA: Pfizer will pull ineffective leukemia drugThe Associated Press
Pfizer to Pull Cancer Drug Mylotarg from MarketFOXBusiness
BusinessWeek -The Star-Ledger - NJ.com -Daily Markets
all 255 news articles »
More...